11
18
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T77075 | Spartalizumab | PDR001 | PD-1/PD-L1 |
Spartalizumab (PDR001) is a humanized immunoglobulin 4 monoclonal antibody that selectively binds to PD-1 at low concentrations and shows high activity. Spartalizumab blocks the interaction with PD-L1 and PD-L2, and can ... | |||
T9902 | Atezolizumab | Apoptosis , PD-1/PD-L1 , Autophagy | |
Atezolizumab anti-PD-L1) is a fully humanized IgG1 monoclonal antibody that blocks the interaction of PD-L1 with both PD-1 and B7.1 but not the interaction of PD-L2 with PD-1. | |||
T35394 | Sintilimab (anti-PD-1) | IBI308,Sintilimab (anti-PD-1) | PD-1/PD-L1 |
Sintilimab (IBI308) is a humanized IgG4 monoclonal antibody with significant anti-tumor activity that restores endogenous anti-tumor T-cell responses by binding to PD-1 and thereby blocking the interaction of PD-1 with i... | |||
T76850 | Dostarlimab | ||
Dostarlimab (TSR-042) is a humanized monoclonal antibody targeting PD-1 with high affinity, designed to block its interaction with ligands PD-L1 and PD-L2. By competitively inhibiting these interactions, it achieves IC50... | |||
T77023 | Geptanolimab | ||
Geptanolimab (CBT-501), a humanized IgG4κ monoclonal antibody targeting PD-1 (Programmed Death-1), functions by competitively inhibiting the interaction between PD-L1/L2 and PD-1, thereby possessing potential use in canc... | |||
TP1075 | AUNP-12 TFA (1353563-85-5 free base) | AUNP-12 TFA,NP-12 TFA | |
AUNP-12 TFA (NP-12 TFA) is a polypeptide antagonist in the pd-1 signaling pathway, which has the same antagonistic effect on pd-l1 and pd-l2, and can protect the proliferation and effector function of lymphocytes. | |||
T77003 | Ezabenlimab | ||
Ezabenlimab (BI-754091) is an anti-PD-1 monoclonal antibody (mAb) that exhibits a binding constant (Kd) of 6 nM in CHO cells. It effectively inhibits the interaction between PD-1 and its ligands, PD-L1 and PD-L2, enhanci... | |||
T76020 | AUNP-12 TFA | ||
AUNP-12 TFA (NP-12 TFA), a peptide antagonist of the PD-1 signaling pathway, exhibits equipotent antagonism toward PD-L1 and PD-L2, enhancing lymphocyte proliferation and effector functions. It promotes immune activation... | |||
T76985 | Tebotelimab | ||
Tebotelimab (MGD-013) is a bispecific antibody targeting PD-1 and LAG-3, classified as a human IgG4κ dual-affinity re-targeting (DART) molecule. It exhibits binding affinities with EC50 values of 1.65 nM for PD-1 and 0.4... | |||
T35396 | Spartalizumab (anti-PD-1) | PD-1/PD-L1 | |
Spartalizumab (anti-PD-1) is a useful organic compound for research related to life sciences and the catalog number is T35396. | |||
T76945 | Cetrelimab | ||
Cetrelimab (JNJ 63723283; JNJ 3283), a humanized IgG4κ monoclonal antibody (mAb) targeting PD-1, binds to PD-1 (Kd=1.72 nM, HEK293) to prevent its interaction with PD-L1 and PD-L2 (IC50s=111.7 ng/mL and 138.6 ng/mL, resp... |
Cat No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-04346 | PD-L2 Protein, Human, Recombinant (His) | Human | HEK293 Cells |
PD-L2 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 24 kDa and the accession number is Q9BQ51-1. | |||
TMPY-05827 | PD-L2 Protein, Human, Recombinant (mFc) | Human | HEK293 Cells |
PD-L2 Protein, Human, Recombinant (mFc) is expressed in HEK293 mammalian cells with mFc tag. The predicted molecular weight is 48.93 kDa and the accession number is Q9BQ51-1. | |||
TMPY-04957 | PD-L2 Protein, Human, Recombinant (His), Biotinylated | Human | HEK293 Cells |
PD-L2 Protein, Human, Recombinant (His), Biotinylated is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 24 kDa and the accession number is Q9BQ51-1. | |||
TMPY-02352 | PD-L2 Protein, Mouse, Recombinant (His) | Mouse | HEK293 Cells |
PD-L2 Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 24 kDa and the accession number is Q9WUL5. | |||
TMPY-02436 | PD-L2 Protein, Mouse, Recombinant (hFc) | Mouse | HEK293 Cells |
PD-L2 Protein, Mouse, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 49.5 kDa and the accession number is Q9WUL5. | |||
TMPY-05282 | PD-L2 Protein, Mouse, Recombinant (His), Biotinylated | Mouse | HEK293 Cells |
PD-L2 Protein, Mouse, Recombinant (His), Biotinylated is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 24 kDa and the accession number is Q9WUL5. | |||
TMPY-00120 | PD-L2 Protein, Human, Recombinant (hFc) | Human | HEK293 Cells |
PD-L2 Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 49.3 kDa and the accession number is Q9BQ51-1. | |||
TMPK-00166 | PD-L2 Protein, Human, Recombinant (His & Avi) | Human | HEK293 Cells |
PD-1 ligand 2 (PD-L2) as a second ligand for PD-1 and compare the function and expression of PD-L1 and PD-L2. Engagement of PD-1 by PD-L2 dramatically inhibits T cell receptor (TCR)-mediated proliferation and cytokine pr... | |||
TMPK-01290 | PD-L2 Protein, Cynomolgus, Recombinant (aa 20-220, His) | Cynomolgus | HEK293 Cells |
PD-1 ligand 2 (PD-L2) as a second ligand for PD-1 and compare the function and expression of PD-L1 and PD-L2. Engagement of PD-1 by PD-L2 dramatically inhibits T cell receptor (TCR)-mediated proliferation and cytokine pr... | |||
TMPY-06281 | PD-L2 Protein, Human, Recombinant (hFc & Avi), Biotinylated | Human | HEK293 Cells |
PD-L2 Protein, Human, Recombinant (hFc & Avi), Biotinylated is expressed in HEK293 mammalian cells with hFc and Avi tag. The predicted molecular weight is 51.09 kDa and the accession number is Q9BQ51-1. | |||
TMPY-05613 | PD-L2 Protein, Human, Recombinant (His & Avi), Biotinylated | Human | HEK293 Cells |
PD-L2 Protein, Human, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with His and Avi tag. The predicted molecular weight is 25.8 kDa and the accession number is Q9BQ51-1. | |||
TMPY-04225 | PD-L2 Protein, Rat, Recombinant (His) | Rat | HEK293 Cells |
PD-L2 Protein, Rat, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 23.9 kDa and the accession number is D4AAV6. | |||
TMPY-04223 | PD-L2 Protein, Rat, Recombinant (hFc) | Rat | HEK293 Cells |
PD-L2 Protein, Rat, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 49.2 kDa and the accession number is D4AAV6. | |||
TMPY-06819 | PD-L2 Protein, Rhesus, Recombinant (hFc) | Rhesus | HEK293 Cells |
PD-L2 Protein, Rhesus, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 49.6 kDa and the accession number is A4GW30. | |||
TMPY-06838 | PD-L2 Protein, Rhesus, Recombinant (His) | Rhesus | HEK293 Cells |
PD-L2 Protein, Rhesus, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 24 kDa and the accession number is NP_001077068.1. | |||
TMPY-03404 | PD-L2 Protein, Cynomolgus, Recombinant (hFc) | Cynomolgus | HEK293 Cells |
PD-L2 Protein, Cynomolgus, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 49.6 kDa and the accession number is A4GW30. | |||
TMPY-03738 | PD-L2 Protein, Cynomolgus, Recombinant (His) | Cynomolgus | HEK293 Cells |
PD-L2 Protein, Cynomolgus, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 24 kDa and the accession number is A4GW30. | |||
TMPJ-00181 | PD-1 Protein, Human, Recombinant (His & Avi), Biotinylated | Human | HEK293 Cells |
Programmed cell death protein 1(PDCD1) is a single-pass type I membrane protein and contains 1 Ig-like V-type domain. PD-1 is a member of the extended CD28/CTLA-4 family of T cell regulators. PDCD1 inhibits the T-cell pr... |